MCB
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
MCB Accepts, published online ahead of print on 2 January 2008
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
MCB.02130-07v1
28/6/2023    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, J.-Y.
Right arrow Articles by Seo, S.-B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, J.-Y.
Right arrow Articles by Seo, S.-B.

 Previous Article  |  Next Article 

Mol. Cell. Biol. doi:10.1128/MCB.02130-07
Copyright (c) 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Multiple myeloma-related WHSC1/MMSET isoform RE-IIBP is a histone methyltransferase with transcriptional repression activity

Ji-Young Kim, Hae Jin Kee, Nak-Won Choe, Sung-Mi Kim, Gwang-Hyeon Eom, Hee Jo Baek, Hyun Kook, Hoon Kook*, and Sang-Beom Seo*

Department of Life Science, College of Natural Sciences, Chung-Ang University, Seoul 156-756; Medical Research Center for Gene Regulation and Departments of Pharmacology and Pediatrics, Chonnam National University Medical School, Gwang-ju, 501-746, Korea

* To whom correspondence should be addressed. Email: hoonkook{at}chonnam.ac.kr. sangbs{at}cau.ac.kr.


   Abstract

Histone methylation is crucial for transcriptional regulation and chromatin remodeling. The SET-domain containing protein RE-IIBP (interleukin-5 response element II binding protein) has been suggested that it may perform a function in the carcinogenesis of certain tumor types, including myeloma. However, the pathogenic role of RE-IIBP in those diseases remains to be clearly elucidated. In this study, we have conducted an investigation into the relationship between the histone-methylating activity of RE-IIBP and transcriptional regulation. Here, we report that RE-IIBP is up-regulated in the blood cells of leukemia patients, and characterized the H3-K27 methyltransferase activity of RE-IIBP. Point mutant analysis revealed that SET-domain cysteine 483 and arginine 477 are critical residues for the Histone Methyltransferase (HMTase) activity of RE-IIBP. RE-IIBP also represses basal transcription via HDAC recruitment, which may be mediated by H3-K27 methylation. In the chromatin immunoprecipitation assays, we showed that RE-IIBP over-expression induces histone H3-K27 methylation, HDAC recruitment, and histone H3 hypo-acetylation on the IL-5 promoter and represses expression. Conversely, short hairpin RNA-mediated knockdown of RE-IIBP reduces histone H3-K27 methylation and HDAC occupancy around the IL-5 promoter. These data illustrate the important regulatory role of RE-IIBP in transcriptional regulation, thereby pointing to the important role of HMTase activity in carcinogenesis.







Home Help [Feedback] [For Subscribers] [Archive] [Search] --
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2008 by the American Society for Microbiology. All rights reserved.